Richard Dimelow
5PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 25, 2024
Extrapolation of the Efficacy and Pharmacokinetics of Belimumab to Support its Use in Children with Lupus Nephritis.Richard Dimelow, Lia Liefaard, Yulia Green
|Sep 25, 2024
Inter-regional pharmacokinetics and exposure-response analyses of belimumab in patients with system lupus erythematosus.Junyi Wu, Xuan Zhou, Richard Dimelow
|Mar 29, 2024
Longitudinal modeling of efficacy response in patients with lupus nephritis receiving belimumab.Monica Simeoni, Shuying Yang, Debra J Tompson
|Feb 28, 2023
Population model-based analysis of the memory B-cell response following belimumab therapy in the treatment of systemic lupus erythematosus.Richard Dimelow, William R Gillespie, Andre van Maurik
|Jul 30, 2021
Assessment of the safety, pharmacokinetics and pharmacodynamics of GSK3335065, an inhibitor of kynurenine monooxygenase, in a randomised placebo-controlled first-in-human study in healthy volunteers.Disala Fernando, Richard Dimelow, Ciara Gorey
Pageof 1
